Home > Insider Trading > Filing (0001458177-10-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1333763	Chelsea Therapeutics International Ltd.	CHTP	Biological Products, (No Disgnostic Substances) (2836)	203174202

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1239242	E Bryan Roberts	C/O Venrock 3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1365618	D Anders Hove	C/O Venrock 530 Fifth Avenue New York NY 10036	No	No	Yes	No
1458177	Venrock Healthcare Capital Partners Lp	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1479354	Vhcp Co-Investment Holdings, Llc	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No
1479355	Vhcp Management, Llc	3340 Hillview Avenue Palo Alto CA 94304	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-09-20	83,691	$6.30	3,024,253	No	4	S	Indirect	By Fund
Common Stock	Disposition	2010-09-20	15,309	$6.30	553,217	No	4	S	Indirect	By Fund

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Fund
No	4	S	Indirect	By Fund

Footnotes

Consists of shares of common stock held directly by Venrock Healthcare Capital Partners, L.P. ("VHCP LP"). VHCP Management, LLC ("VHCP Management") is the general partner of VHCP LP and may be deemed to beneficially own these shares. Messrs. Anders Hove and Bryan Roberts are the managing members of VHCP Management and may be deemed to beneficially own these shares. Each reporting person disclaims beneficial ownership of these shares, except to the extent of his or its respective pecuniary interest therein.
Consists of shares of common stock held directly by Venrock Co-Investment Holdings, LLC ("Venrock Co-Investment"). VHCP Management is the manager of Venrock Co-Investment and may be deemed to beneficially own these shares. Messrs. Hove and Roberts are the managing members of VHCP Management and may be deemed to beneficially own these shares. Each reporting person disclaims beneficial ownership of these shares, except to the extent of his or its respective pecuniary interest therein.